Best Hematologists for Sickle Cell Disease in India
This page lists 16 sickle cell disease doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
Quick answer
This page lists 16 sickle cell disease doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Sickle Cell Disease doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
About the Condition
What is Sickle Cell Disease?
Sickle cell disease (SCD) is a serious inherited blood disorder in which red blood cells take on an abnormal rigid, crescent shape, impairing their ability to carry oxygen efficiently and causing them to block small blood vessels. Over time this can damage virtually any organ system, leading to complications such as painful vaso-occlusive crises, acute chest syndrome, stroke, avascular necrosis, chronic kidney disease, pulmonary hypertension, and increased susceptibility to serious infections. Disease severity varies considerably between individuals and is influenced by the specific genetic subtype inherited, co-existing conditions, and access to ongoing care. A full clinical assessment — including personal and family medical history, physical examination, and targeted investigations — is essential to understand how the disease is affecting a particular patient and to guide treatment decisions.
Individual assessmentEvery case is different
Complete evaluationUnderstand the condition first
Specialist reviewChoose the right approach
Medical assessment helps clarify severity and identify appropriate options.
Treatment options for Sickle Cell Disease
Care may include lifestyle changes, medical treatment, specialist review or a procedure, depending on the diagnosis, associated conditions and individual goals. The options below are associated with this condition in the GAF Healthcare directory.
Allogeneic Bone Marrow Transplant involves replacing a patient's diseased or malfunctioning bone marrow with healthy blood-forming stem cells from a matched donor.
Why it may be consideredIt is a curative treatment option for conditions like Sickle Cell Disease and Severe Combined Immunodeficiency (SCID), aiming to restore normal blood cell and immune function. India offers this complex procedure at leading transplant centers with internationally trained hematologists at a fraction of Western costs.
Sickle Cell Disease (SCD) management ranges from long-term supportive care with hydroxyurea and transfusions to curative Allogeneic Bone Marrow/Stem Cell Transplant (BMT), which replaces the patient's defective bone marrow with healthy donor stem cells.
Why it may be consideredCurative transplant is typically recommended for patients with severe, recurrent complications (strokes, acute chest syndrome, frequent crises) who have a suitable donor. India offers internationally accredited BMT centers with experienced pediatric and adult hematology teams at significantly lower cost than Western countries.
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Many international patients consider India for sickle cell disease treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
How this directory is built
Doctors are matched using the specialty, location, condition (Sickle Cell Disease) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Sickle Cell Disease in India
What is Sickle Cell Disease?
Sickle cell disease is a group of inherited red blood cell disorders caused by a mutation in the haemoglobin gene, resulting in haemoglobin S (HbS), which distorts red blood cells into a stiff sickle shape. The most common and typically most severe form is haemoglobin SS disease (HbSS), though other variants such as HbSC and HbS-beta thalassaemia also fall under the SCD umbrella.
What are the symptoms and health risks of Sickle Cell Disease?
Common manifestations include recurrent episodes of severe pain (vaso-occlusive or 'sickle cell' crises), fatigue and anaemia, swelling of the hands and feet (dactylitis, particularly in young children), frequent infections, delayed growth, and vision problems. More serious acute complications — including acute chest syndrome, stroke, and splenic sequestration — can be life-threatening and require urgent medical attention. Because many of these symptoms overlap with other conditions, experiencing them does not confirm a diagnosis of sickle cell disease; formal testing is always required.
How is Sickle Cell Disease diagnosed?
Diagnosis is typically confirmed through haemoglobin electrophoresis or high-performance liquid chromatography (HPLC), which identify the specific haemoglobin variants present, and is often first detected through newborn screening programmes. Further investigations used to assess disease burden and guide management include full blood count (to gauge baseline haemoglobin and reticulocyte count), transcranial Doppler ultrasound (to screen for stroke risk in children), organ function tests (renal, hepatic, pulmonary), and, where transplant is being considered, HLA typing of the patient and potential donors. Genotyping confirms the precise SCD subtype — such as HbSS, HbSC, or HbS-beta⁰/beta⁺ thalassaemia — which strongly influences prognosis and treatment planning.
How is Sickle Cell Disease treated?
Treatment is tailored to disease severity, complication history, age, and the availability of suitable donors, and ranges from ongoing medical management through to curative procedures. For patients with severe or refractory disease, allogeneic bone marrow (stem cell) transplantation currently represents the only established curative option and is evaluated on a case-by-case basis by a specialist team. All treatment decisions — including whether and when to pursue transplantation — should be made in close consultation with a qualified clinician who has reviewed the individual's full clinical picture.
Can Sickle Cell Disease be treated without surgery?
Medical management forms the cornerstone of care for the majority of patients and includes hydroxyurea (hydroxycarbamide), which reduces the frequency of painful crises and acute chest syndrome in eligible patients; regular blood transfusion programmes to lower HbS levels and reduce stroke risk; prophylactic antibiotics and vaccinations to reduce infection risk; and pain management protocols for acute crises. Newer disease-modifying agents — including voxelotor and crizanlizumab — may be recommended in certain cases, subject to availability and individual clinical assessment. These approaches do not cure the disease but can significantly reduce complications and improve quality of life.
When is Allogeneic Bone Marrow Transplant considered for Sickle Cell Disease?
Allogeneic Bone Marrow Transplant may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.
Which doctor treats Sickle Cell Disease?
Sickle cell disease is typically managed by a haematologist specialising in haemoglobinopathies or a sickle cell disease specialist; in cases where transplantation is being considered, a haematologist with expertise in bone marrow transplantation (BMT physician) leads the evaluation. Paediatric patients are usually under the care of a paediatric haematologist, and ongoing multidisciplinary input — from nephrologists, pulmonologists, neurologists, ophthalmologists, and pain specialists — is often necessary given the multi-organ nature of the disease.
How do I choose a doctor for Sickle Cell Disease?
When comparing providers, prioritise centres with a dedicated sickle cell or haemoglobinopathy programme, demonstrable experience in allogeneic transplantation (including matched unrelated and haploidentical donor protocols) if transplant is relevant to your case, and access to a full multidisciplinary team for long-term follow-up and complication management. It is also worth asking specifically about the centre's experience managing patients with your SCD subtype and complication history, as outcomes can vary meaningfully between programmes.
What documents do international patients need to share for a medical evaluation?
Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.
